Bullish
$ADMA I like this trajectory looking at the numbers. First 6 months of 2019, product revenue is $10M and cost of product revenue is $20M. 3rd quarter of 2019, product revenue is $7.2M and cost of product revenue is $7.9M. 4th quarter of 2019, product revenue is $11.9M and cost of product revenue is?? Look like they manage to maximize the plant’s efficiency and reduce the COGS..This isn’t exciting like some other biotech but it’s stable growth for me. ADMA is a must have in any biotech growth portfolio.
  • 29
  • 8